Study on the efficacy of topical semi-solid Rosa damascena product in treatment of chronic hand eczema

Phase 3

Recruiting

• Conditions: Chronic hand Eczema.; (chronic) eczema; L20.83

• Registration Number: IRCT20150825023753N18
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

A patient aged 18 to 65 years with a diagnosis of chronic eczema by a dermatologist
The patient's cooperation to eliminate or reduce environmental irritants and is bound to cooperate for regular use of the studied drug and referral enters the research project at the appointed time after signing the informed consent form.
The patient agrees to participate in the study

Exclusion Criteria

Patient dissatisfaction with participation in the study
Severe or refractory eczema that requires oral or topical steroids.
Use topical medications during 2 weeks before starting the research project
Use of systemic immunosuppressive drugs during one month before starting the research project
Having obsessive-compulsive disorder for frequent hand washing
Patients suspected of having concomitant fungal diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified